U.S. senators urge State Department to restore Gavi funding

U.S. senators urge State Department to restore Gavi funding
Senators push Gavi funding

A bipartisan group of U.S. senators is pressing the State Department to release already appropriated funds for Gavi, the global vaccine alliance. The lawmakers say $600 million approved for fiscal years 2025 and 2026 should be used to replenish U.S. support for the organization and sustain the country’s role in global vaccination efforts.

Highlights

  • Six U.S. senators sent a letter on May 4 urging the State Department to use the $600 million appropriated for Gavi funding in fiscal years 2025 and 2026.
  • Gavi has facilitated the vaccination of over 1.1 billion children and prevented 20.6 million deaths since 2000, with 19 countries graduating from its support.
  • The senators emphasized Gavi's $12.5 billion in purchases of U.S.-manufactured vaccines and warned the U.S. risks losing board influence affecting domestic health security.

Congressional push for vaccine funding

As reported by Senate Committee on Finance Minority Press, the letter was sent on May 4 by Senators Jeanne Shaheen, Susan Collins, Patty Murray, Mitch McConnell, Brian Schatz and Lisa Murkowski to Secretary of State Marco Rubio. The lawmakers question why the department has not used the $600 million appropriated across fiscal years 2025 and 2026, $300 million in each year, to restore the U.S. government’s pledge to Gavi.

In the letter, the senators describe Gavi as a public-private health partnership that has vaccinated more than 1.1 billion children and helped prevent 20.6 million deaths since 2000. They argue the group helps contain outbreaks before they reach U.S. borders and say its funding model supports long-term country ownership of vaccine programs, with 19 countries already graduated from Gavi support.

Implications for U.S. industry and health security

The senators also frame Gavi as supporting domestic economic interests, saying the alliance has purchased more than $12.5 billion in U.S.-manufactured goods and vaccines. They add that Gavi is the world’s largest purchaser of U.S.-produced vaccines and hosts the U.S.-founded global vaccine stockpile.

The letter says restoring the contribution is necessary for the United States to regain a seat on Gavi’s board. Without that position, the senators say, the country cannot directly influence technical, financial and scientific decisions that affect U.S. health security.

In our earlier coverage of senators urging the State Department to restore Gavi funding, we explained that bipartisan lawmakers want the department to release $600 million appropriated for FY 2025 and FY 2026 to renew the U.S. pledge to the vaccine alliance. We also noted their argument that funding Gavi supports U.S. health security and domestic industry, and that restoring the contribution would help the United States regain a seat on Gavi’s board.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.